Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
설정
언어
한국어
통화
USD
테마
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
주식 순위 #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
주가
$59.98
마지막 동기화: 2024-12-13
시가총액
$1.22B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Longboard Pharmaceuticals, Inc. (LBPH)

카테고리

Healthcare
Longboard Pharmaceuticals, Inc. (LBPH)의 매출
Sep 2024 기준 매출 TTM: $8.00K
Longboard Pharmaceuticals, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $8.00K입니다. 2022년에 회사는 0.00의 수익을 올렸으며 이는 2021년의 0.00 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Longboard Pharmaceuticals, Inc.의 수익 기록 (2020 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $8.00K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,803,650.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,265,991.36%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 196,803,989.28%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 27,849,900.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH